PB

Pranay Bawari

Director Director DIN 07638239
DIN 07638239 First appointment Oct 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2016
Shareholding value •••• Premium profile

About Pranay Bawari

Data last updated:

Pranay Bawari was a Director at Epione Med Rx Pharmacy Private Limited (2016–2018) and Director at Bawson Surgicals Private Limited (2020–2022). The companies operate in Pharma and Trading.

DIN 07638239
Primary Designation Director
Industry Pharma
First Appointment 24 Oct 2016

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Oct 20162016₹1.8 Lakh (FY 2023)Strike Off
Bawson Surgicals Private Limited U51909AS2020PTC020162
Director03 Jul 20202020₹1.72 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Epione Med Rx Pharmacy Private Limited
Bawson Surgicals Private Limited
Premium access

Shareholding and investment profile for Pranay Bawari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pranay Bawari

Pranay Bawari was first appointed on 24 Oct 2016 as Director at Epione Med Rx Pharmacy Private Limited. The most recent appointment on record is 03 Jul 2020 at Bawson Surgicals Private Limited.

Pranay Bawari held 2 earlier board appointments: Epione Med Rx Pharmacy Private Limited (Director, 24 Oct 2016 to 24 Aug 2018); Bawson Surgicals Private Limited (Director, 03 Jul 2020 to 01 May 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available